Leen Kawas and the Work of Carrying Promising Medicines Forward

Leen Kawas and the Work of Carrying Promising Medicines Forward

Leen Kawas and the Work of Carrying Promising Medicines Forward

EIT Pharma CEO Leen Kawas is advancing lonafarnib for chronic hepatitis D, showing how stalled late-stage drug programs can be revived and carried toward regulatory review.